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Endovascular recanalization of total occlusions of
the mesenteric and celiac arteries
Mel J. Sharafuddin, MD,a,b Rachael M. Nicholson, MD,a Timothy F. Kresowik, MD,a Parth B. Amin, MD,a
Jamal J. Hoballah, MD,a andWilliam J. Sharp, MD,a Iowa City, Iowa
Objective: To evaluate our experience with the endovascular treatment of total occlusions of the mesenteric and celiac
arteries.
Methods:We performed a retrospective review of endovascular stenting of 27 nonembolic total occlusions of the superior
mesenteric artery (SMA) and celiac artery (CA) between July 2004 and July 2011 (26 patients, 16 females; mean age,
62  13 years). A variety of demographic, lesion-related and procedure-related variables were evaluated for potential
impact of technical success and patency. The follow-up protocol included clinical assessment, and color and spectral
Doppler evaluation of the stented vessel(s).
Results: The clinical presentation was chronic mesenteric ischemia in 12 patients, acute mesenteric vascular syndromes in
10 patients, foregut ischemia/ischemic pancreatitis in three patients, and prior to endovascular repair of aortic aneurysm
in one patient. The treated vessel was SMA in 22 procedures, CA in three, and both SMA andCA in one. Technical success
was achieved in 23 of the 27 attempted recanalizations (85%). Three patients who failed the attempt underwent open
bypass, and another one underwent retrograde recanalization and stenting of the SMA. Procedure success was only
significantly related to patient age <70 years or procedure performance after the year 2006. Notably, the presence of a
stump, ostial plaque, extensive vascular calcification, recanalization route (intraluminal vs subintimal), occlusion length,
and vessel diameter had no significant impact on procedure success. Traditional duplex criteria proved unreliable in
predicting restenosis. Life table analysis of freedom from symptom recurrence showed a primary and assisted rates of 58%
and 80% at 1 year, and 33% and 60% at 2 years, respectively. Clinical recurrences developed in six patients (four presented
with abdominal angina and weight loss, two presented with abdominal catastrophe). There were six access-related
complications and no procedural deaths. Four delayed deaths occurred during follow-up (two cardiac causes, two due to
abdominal sepsis).
Conclusions: Endovascular recanalization of mesenteric artery occlusion is both feasible and successful, provided careful
planning is used. (J Vasc Surg 2012;55:1674-81.)
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pWhile asymptomatic mesenteric vascular occlusive
disease (MVOD) occurs commonly in patients with es-
tablished vascular risk factors,1 progression to symptom-
atic mesenteric ischemia can develop, especially in pa-
tient with two- and three-vessel disease. Endovascular
treatment in symptomatic mesenteric occlusive disease
represents a viable option, especially in high-operative-
risk patients.2 However, the role of endovascular treat-
ment in patients presenting with acute mesenteric syn-
dromes (acute or acute-on-chronic mesenteric ischemia)
is controversial. The presence of total occlusions repre-
sents a major obstacle to successful endovascular treat-
ment of MVOD.3-5 Total occlusions are commonly en-
countered in symptomatic MVOD patients, especially
patients presenting with the acute syndromes. Despite
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1674he growing experience and skills in the endovascular
anagement of MVOD, total occlusion of the mesen-
eric vessels continues to be controversial, and is even
onsidered an indication for open surgery in the setting
f symptomatic MVOD.3 However, open mesenteric
evascularization procedures, including bypass or endar-
erectomy, carry a substantial mortality and morbidity
isks, especially in the typically malnourished patients,
ith extensive cardiovascular risk factors.6
The purpose of this study is to evaluate our experience
ith the endovascular treatment of total occlusions of the
esenteric and celiac arteries.
ETHODS
We conducted a retrospective review of our departmen-
al experience with endovascular stenting of the superior
esenteric artery (SMA) and celiac artery (CA) between
uly 2004 and July 2011. Only patients who underwent
ttempted recanalization of a total occlusion of either SMA
r CA were included in the study. Embolic occlusions were
xcluded. During the study period, a total of eight patients
nderwent an open mesenteric bypass procedure, exclud-
ng those done in conjunction with aneurysm repair. This
gure includes three patients who underwent open bypass
ollowing failed endovascular recanalization. The study
opulation consisted of a total of 27 nonembolic total
cclusions that were targeted endovascularly with the in-
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Volume 55, Number 6 Sharafuddin et al 1675tent to treat in 26 patients. There were 16 females and 10
males (mean age, 62  13 years). The clinical characteris-
tics of the study population are listed in Table I. The clinical
presentation was chronic mesenteric ischemia (CMI) in 12
patients, manifesting in postprandial abdominal angina and
weight loss. Acute mesenteric ischemia (AMI) was defined
by the presence of any combination of persistent abdominal
pain, mild peritoneal signs, leukocytosis, and lactic acidosis.
Imaging findings were also used to rule out AMI, especially
computerized tomography (CT). Acute-on-chronic mes-
enteric ischemia (AOCMI) referred to an acute presenta-
tion with a prior history of abdominal angina or weight loss
10 pounds. Another group of patients with an acute
presentation were those who had a presentation related to
foregut ischemia (postprandial pain, nausea with ischemic
ulcers of the stomach and duodenum), suspected ischemic
pancreatitis, or suspected ischemic hepatitis. However,
these patients were considered separate from those present-
ing with AMI syndromes (AMI or AOCMI). One patient
underwent SMA recanalization prior to endovascular aneu-
rysm repair to lower the risk of mesenteric ischemia follow-
ing exclusion of the inferior mesenteric artery. Outcomes
were evaluated on an intent-to-treat basis. Any patient who
underwent an unsuccessful attempt at endovascular recan-
alization with subsequent open revascularization was con-
sidered a procedural failure.
Presentation with an AMI syndrome (AMI or
AOCMI) was identified in 10 patients (38%). Of those,
four patients first underwent exploratory laparotomy to
assess bowel viability and/or manage intra-abdominal
complications such as bowel gangrene, enterocutaneous
fistula, or abdominal abscess. Two of these patients under-
went a revascularization attempt during the laparotomy
procedure. In one patient, we attempted open revascular-
ization, which was aborted due to an extremely hostile
abdomen, in favor of an endovascular revascularization
attempt. Another patient had an unsuccessful percutaneous
recanalization attempt of an occluded SMA, and a hybrid
Table I. Summary of clinical presentation and vascular
risk factors
Indication for intervention No.
Chronic mesenteric ischemia 12
Acute mesenteric ischemia or acute-on-chronic
mesenteric ischemia
10
Foregut ischemia, ischemic pancreatitis/hepatitis 3
Prior to endovascular aneurysm repaira 1
Vascular risk factors No.
Tobacco abuse 23
Hyperlipidemia 21
Hypertension 16
Diabetes mellitus 4
Hypercoagulable state 2
Chronic renal failure 1
aCeliac artery and superior mesenteric artery occlusion.retrograde recanalization approach was used, allowing suc- aessful stenting of the SMA. That patient was considered a
rocedure failure. The remaining two patients underwent
egmental resection of necrotic bowel and/or repair of
nteric fistulae, with the remaining bowel appearing viable.
ubsequent endovascular revascularization was performed
n both in a formal angiography suite. In one additional
atient, vascular consultation was requested 48 hours after
he onset of symptoms, following failed endovascular re-
analization by another service. The general surgery service
as consulted, and we proceeded with endovascular recan-
lization, followed by an intraperitoneal bowel exploratory
rocedure.
Preprocedural CT scans were carefully examined for
ssociated thrombus in the reconstituted vessel. Thrombus
as suspected based on CT in two patients. In one, pulse-
pray thrombolysis was performed following which stent-
ng was accomplished. In the other patient, we used an
CAST balloon-expanded stent graft (Atrium Medical,
udson, NH) without thrombolysis. Thrombus burden
as felt to be small in both patients, and postdeployment
ngiography showed no evidence of major embolism. All
rocedures were performed under therapeutic systemic
eparinization. Following the intervention, all patients
ere maintained on either therapeutic warfarin (n  5) or
lopidogrel 75 mg orally daily in addition to aspirin 81 to
25 mg orally daily (n  21).
Successful recanalization appeared to be most depen-
ent on the identification of an appropriate probing point
o initiate the recanalization sequence and a stable catheter
osition. In our experience, this often necessitated a bra-
hial approach. Coaxial support using a flexible sheath was
rucial in transfemoral procedures. Once a stable platform
as achieved, the stump is probed with an appropriate
atheter/glide wire combination. The most useful combi-
ations were multipurpose angiographic catheter/angled
lide wire from a brachial approach, or Simmons-1 or -2
atheter/angled glide wire from a transfemoral approach.
n patients with flush occlusions and no visible stump,
hich we termed “obliterated stump,” we have found that
orrelation with preoperative cross-sectional imaging (usu-
lly CT) is critical for the localization of the obliterated
tump, usually in reference to a radio-opaque landmark or
n adjacent patent vessel such as the renal artery (Fig 1).
lternatively, in the presence of heavy vascular calcifica-
ions, the location of the stump can be estimated according
o the calcification pattern. Good fluoroscopic capability in
he lateral projection is crucial during those attempts, and a
rachial approach is nearly always needed. Through a stable
upport sheath or guide catheter platform, angled angio-
raphic catheters with a guide wire are used coaxially to
robe the obliterated stump. Occasionally, traversal of the
cclusion is accomplished easily, but at times, it may require
n incremental advancement (burrowing) approach (Fig
). Once intraluminal reentry is achieved, the position is
erified with contrast injection, the occlusion is predilated,
nd stenting is accomplished in a standard manner.
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June 20121676 Sharafuddin et alFig 1. Example of recanalization of occluded superior mesenteric artery (SMA) in the setting of an obliterated stump
in a 47-year-old woman who presented with an acute abdomen. During exploratory laparotomy, she was found to have
an intra-abdominal abscess with extensive inflammation, segmental of patchy ischemia of the small bowel, and a
pulseless mesentery. Revascularization was deemed difficult given the hostile abdomen. A, Lateral reconstruction of a
contrast-enhanced computerized tomography (CT) of the abdomen shows occlusion of the celiac artery (CA) and SMA
with no visible stumps. B, Axial slice demonstrates an obliterated stump of the SMA, which is just above the takeoff of
the renal arteries. C, Lateral flush aortogram from a brachial approach demonstrates a featureless suprarenal aorta with
no stumps visualized.D, Probing anteriorly at the level of the renal artery engaged the obliterated stump of the SMA,
with subsequent subintimal recanalization. E, Final angiography following deployment of a 5-  28-mm balloon-
expanded stent.
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Volume 55, Number 6 Sharafuddin et al 1677A variety of variables were evaluated for potential im-
pact of technical success and patency. These included:
procedures performed before the year 2006, age, gender,
presentation (acute, acute mesenteric syndrome, chronic),
vascular risk factors, vessel treated, presence of a stump,
heavy calcification, associated ostial plaque, length of the
occluded segment, diameter of the reconstituted index
vessel, access approach, recanalization technique (intralu-
minal vs subintimal), stent diameter, length of stented
segment, and angiographic residual stenosis following
stenting.
The follow-up protocol included clinical assessment,
and color and spectral Doppler evaluation of the stented
vessel on the follow-up visits, usually at 1month, 3months,
Fig 2. Sixty-year-old woman with extensive peripheral v
of eating, and 20-pound weight loss.A, Lateral reconstru
of the abdomen shows a 3-cm-long occlusion of the s
Progressive burrowing at the suspected level of the o
calcifications on fluoroscopy as a reference. C, Ostial ste
track shows recoil of the subintimal track.D, Final appear
shows an optimal anatomic result. E, Angiography show
true lumen fenestration. F, Following scoring balloon an
mid-SMA. G, Final result following placement of a 6- 6months, and 12months, and yearly thereafter. Restenosis sn follow-up was defined by angiographic or duplex docu-
entation of stenosis 70% (peak systolic velocity [PSV]
300 cm/s). However, due to the high rate of elevated
elocities (300 cm/s) observed immediately following
tenting in our experience, we adoptedmore lenient criteria
or assignment of restenosis in stented mesenteric vessels
PSV 400 cm/s). Moreover, we examined the sensitivity
nd specificity of duplex sonography in 23 patients who had
oth duplex and clinical follow-up available. Using the PSV
300 cm/s criterion, there were eight false positives, four
rue positives, and one false negative. When the PSV400
m/s criterion was used, there were only two false positives,
hile the true positives and false negative remained at four
nd one. Symptoms recurrence or development of progres-
ar disease presenting with severe postprandial pain, fear
of a contrast-enhanced computerized tomography (CT)
or mesenteric artery (SMA) with no visible stump. B,
ated SMAP stump, using the celiac artery and visible
of the SMA with balloon dilatation of the recanalized
following prolonged inflation of 5-mm balloon diameter
stent restenosis and restenosis/recoil of the subintimal-
lasty, there is improved flow but hazy appearance of the
mm self-expanding nitinol stent.ascul
ction
uperi
bliter
nting
ance
ed in-
giopive increase in velocities on duplex usually prompted cross-
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June 20121678 Sharafuddin et alsectional imaging with CT angiography. When high-grade
preocclusive or rapidly progressive stenosis was identified or
when clinical recurrence of symptoms was suspected and
associated restenosis was confirmed, we proceeded with
mesenteric angiography with the intent to treat any ame-
nable lesions. Primary clinical benefit was defined as free-
dom from symptoms recurrence on the follow-up point.
Primary patency of the treated segment was also evaluated
as “freedom from restenosis,” as assessed by composite
evaluation using PSV 400 cm/s on spectral Doppler
analysis and/or lumen diameter stenosis 70% on CT
angiography. Assisted primary clinical benefit and primary
patency were also assessed, and refer to restoration and
maintenance of freedom from symptoms or patency by
endovascular means, using repeat balloon dilatation
and/or restenting. Thromboses and recurrences that could
not be treated by endovascular means were considered as a
patency loss. Statistical comparison of the various variables
was performed using SYSTAT 11.0 software (SPSS, Inc.,
Chicago, Ill). Univariate analysis of continuous numeric
variables was done using the Student t-test, while the
Pearson 2 probability test was used for comparing non-
numeric categorical variables. Survival analysis was gener-
ated using GraphPad Prism version 5.04 for Windows
(GraphPad Software, San Diego, Calif).
RESULTS
The anatomic patterns of disease and technical details
of the interventions are summarized in Tables II and III.
Although in most procedures, only one stent was used, two
to three stents were required in four procedures. A variety
of balloon-expanded stents were used, including: Express
(Boston Scientific, Natick, Mass), Formula (Cook, Bloom-
ington, Ind ), and Omnilink or Herculink (Abbott, Abbott
Park, Ill).
Using an intent-to-treat analysis, technical success was
achieved in 23 of the 27 recanalization attempts (85%). All
four failures were in SMA occlusions. Three patients who
failed the recanalization attempt underwent an open bypass
procedure. The fourth patient labeled as a technical failure
presented with acute mesenteric syndrome and failed an
Table II. Patterns of anatomic disease and intervention
Disease distribution
Three vessels 6
Two vessels 15
One vessel (SMA) 5
Targeted (index) occluded vessel
SMA 22
CA 3
SMA  CA 1
Additional stenotic vessels treated
SMA 3
CA 5
IMA 1
CA, Celiac artery; IMA, inferior mesenteric artery; SMA, superior mesen-
teric artery.attempt at endovascular recanalization during initial ex- 0loratory laparotomy. She underwent retrograde recanali-
ation and stenting of the SMA in the same setting in the
ybrid operating suite. Interestingly, balloon thrombec-
omy through the SMA arteriotomy yielded no thrombus.
valuation of a variety of patient-related, lesion-related,
nd procedure-related variables showed that procedure
uccess was only significantly related to patient age 70
ears or procedure performance after the year 2006. Nota-
ly, the presence of a stump, ostial plaque, extensive vascu-
ar calcification, recanalization route (intraluminal vs sub-
ntimal), occlusion length, and vessel diameter had no
ignificant impact on procedure success.
Procedure-related complications included five instances
f brachial artery thrombosis/hematoma necessitating explo-
ation with thrombectomy and/or repair. One groin hema-
oma with a femoral pseudoaneurysm was observed in one
atient. Mild azotemia occurred in two patients and resolved
pontaneously. There were no procedure-related deaths.
Clinical improvement was noted in 20 of 21 symptom-
tic patients in whom endovascular recanalization was suc-
essful. The one exception was a patient who had atypical
bdominal symptoms and weight loss. He eventually had
n additional gastroenterological workup, and his symp-
oms and weight loss stabilized on dietary modifications.
nother patient was asymptomatic preoperatively but un-
erwent SMA recanalization prior to an endovascular ab-
ominal aortic aneurysm repair procedure. Of note is that
ll three patients with foregut and pancreaticohepatic
ymptomatology improved with stenting. Clinical and im-
ging follow-up results are summarized in Table IV. The
edian clinical follow-up was 14  11 months (range,
able III. Technical details of 27 recanalization
rocedures
echnical success 23/27 (85%)
esion characteristics
Index vessel diameter 5.5  0.6 mm
Type of stenosis
De novo 25
In-stent restenosis 1
Dissection 1
Length 18.5  6.5 mm
Associated thrombus 2a
Heavy calcification 16
Ostial plaque 13
Stump (2 mm) 14
cclusion recanalization technique
Brachial approach 16
Femoral converted to brachial approach 7
Subintimal 9
Intraluminal 17
tenting details
More than one stent needed 4/23
Stent graft 1
Final stent diameter 5.8  0.6 mm
Stented length 22.3  8.2 mm
Residual stenosis 14.1  15.5 mm
Adjunct thrombolysis 1
Small.-41months). Themedian imaging follow-up was 11 10
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Volume 55, Number 6 Sharafuddin et al 1679months (range, 1-41 months). Life table analysis of free-
dom from symptom recurrence was analyzed (Fig 3). Pri-
mary clinical patency diminished to 58% at 1 year and 33%
at 2 years. Assisted clinical patency at 12 months was 80%
decreasing to 60% at 2 years. Log-rank Cox test showed
significant difference between the two curves (P  .05).
Clinical recurrences developed in six patients and were
all associated with documented restenosis on imaging stud-
ies. Four of the recurrences presented with abdominal
angina and weight loss. All underwent angiography docu-
menting high-grade in-stent restenosis, which were suc-
cessfully treated with balloon angioplasty and/or restent-
ing. This includes one patient who had undergone
subintimal recanalization of a long occlusion with partial
Table IV. Summary of the hemodynamic and clinical
outcomes of interventions
Duplex findings Immediate poststenting On follow-up P
PSV (cm/s) 247  117 313  116 .1
PSV 300 cm/s 6/23 12/25 .06
PSV 400 cm/s 1/23 4/25 .15
Clinical recurrencesa n  6
Median delay 10  2.7 monthsb
Recurrent abdominal angina/weight loss 4
Abdominal catastrophe 2
Deaths
Median delay 22  16 monthsc
Cardiac events 2d
Abdominal catastrophe/sepsis 2e
PSV, Peak systolic velocity.
Median clinical follow-up: 14  11 months (range, 0-41 months). Median
imaging follow-up (11  10 months (range, 1-41 months).
aAll associated with restenosis/reocclusion on imaging.
bRange, 5-11 months.
cRange, 2-43 months.
dAt 19 and 43 months.
eAt 2 and 23 months.
Fig 3. Table analysis of primary and assisted freedom from symp-
toms. Comparison of the primary and assisted curves using log-
rank Cox analysis showed significant difference (P  .05).false lumen reentry. She developed restenosis 1 month sater, which required balloon angioplasty followed by
ong-segment stenting to manage resistant lumen recoil.
he fared well afterwards and remains symptom-free with
on-stenosed duplex examination nearly 11 months later
Fig 2).
Two additional clinical recurrences presented acutely
ith abdominal catastrophe. Both occurred in young pa-
ients with hypercoagulability history and either subthera-
eutic anticoagulation or discontinuation of anticoagula-
ion therapy. In both, reocclusion of an SMA stent had
ccurred, with the CA also being chronically occluded. The
rst patient had undergone recanalization and stenting of
he SMA, followed by second-look surgery with resection
f approximately 3 feet of small intestines. He did well
nitially but later was lost to follow-up. He presented
0 months following the stenting procedure with intra-
bdominal sepsis due to extensive bowel necrosis. Repeat
maging showed development of thrombosis in the SMA in
he segment beyond the occluded stent, which probably
ccounted for his extensive ischemia. Attempted recanali-
ation of the stent was unsuccessful, and the patient de-
lined an open bypass procedure. He eventually required
ubtotal bowel resection and is now parenteral nutrition-
ependent. The second patient initially presented with
owel necrosis, necessitating emergent exploration and
esection of gangrenous small intestine. Intraoperative vas-
ular consultation determined that the abdomen was too
ostile for a bypass, and the patient underwent recanaliza-
ion of an occluded SMA. She did well for nearly 2 years
ith documented patency on duplex sonography. How-
ver, her anticoagulation regimen was completely discon-
inued for an abdominal hernia repair procedure. She pre-
ented 1 week later with abdominal sepsis and was found to
ave extensive bowel necrosis and sepsis. She eventually
uccumbed to multiorgan system failure.
Nominal stent diameter 5 mm and residual stenosis
40% following stenting were both predictive of clinical
ecurrence as well as restenosis on imaging (P  .07 and
 .05, respectively). The remaining studied variables had
o statistical impact, including age, gender, recanalization
oute, lesion morphology, and length of occlusion.
Four deaths occurred during the follow-up at a mean
2 16 months after the procedure. Two deaths were due
o cardiac events (19 and 43 months). Two additional
eaths due to abdominal catastrophe and sepsis occurred at
and 23 months following the procedure.
ISCUSSION
Total occlusions in the mesenteric circulation pose a
articularly difficult challenge, due to the often steep ori-
ntation of these vessels, and anterior origin from the aorta,
hich necessitates a lateral/sagittal plane imaging for ade-
uate profiling. In our experience with 27 SMA and CA
otal occlusions, nearly half had no angiographically visible
tump, which we term “obliterated stump.” Antegrade
ecanalization in those cases would normally be considered
early impossible. We therefore relied on a number of
trategies, which in our experience, resulted in a high rate of
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identify vascular calcifications that could mark the origin of
the SMA or CA, essentially serving as a fluoroscopic marker
of an otherwise occult stump. Otherwise, preoperative con-
trast-enhanced CT has proven very useful in marking the
level and orientation of an obliterated stump, relative to an
adjacent patent vessel to be used as reference point for
exploratory probing of the obliterated stump.
Our study represents the largest reported series on the
endovascular management of totally occluded mesenteric
and celiac arteries. One recent study by Sarac et al reported
on 18 totally occludedmesenteric vessels and compared the
outcome and patency with 47 stenotic lesions.4 It con-
cluded that the results of endovascular treatment of totally
occluded mesenteric arteries are indistinguishable from
those in stenotic vessels. However, our results, when com-
pared with our prior published experience in a population
of mostly stenotic lesions,7 would suggest a lower primary
patency rate with total occlusions, although the retrospec-
tive nature and the time lag between the two studies may
introduce confounding factors that could have contributed
to the discrepant outcomes. Nevertheless, the observed
difference may well be the results of different study designs.
Although not specifically stated in the article, examination
of the report by Sarac et al suggests that patency rates were
compared between lesions that were successfully treated,
whereas our data were analyzed on an intent-to-treat basis,
which could explain our lower primary patency rates.
Moreover, a much higher proportion of the occlusions in
our study were in patients presenting with acute mesenteric
syndromes (40% compared with only 3%). This could have
a negative impact on patency because of the possibility of an
unrecognized associated thrombotic component in the oc-
clusions or possibly unfavorable biological response to
stenting.
We have observed potentially serious drawbacks of
subintimal recanalization in severely diseased and calcified
vessels where reentry into the true lumen occurred beyond
the point of reconstitution. This may have serious conse-
quences such as accelerated restenosis and clinical recur-
rence, which we observed in the patient described above,
who developed symptomatic restenosis less than a month
after the procedure. She underwent reintervention and
eventually required stenting of a long segment of the
proximal through mid-SMA to maintain patency (Fig 2).
The importance of multivessel revascularization has
been repeatedly stressed in the surgical literature as a major
advantage to open revascularization.3 A particularly “at-
risk” group of patients with MOVD include those with
total occlusion of both the SMA and CA who undergo
“single-vessel” endovascular revascularization. Such pa-
tients are at high risk of developing a catastrophic event if
the stented vessel becomes occluded. As a result, in patients
with occluded SMA and severe disease of the celiac, our
approach should likely shift to attempting stenting of a
second diseased or occluded vessel to effectively achieve
dual mesenteric revascularization. Even subsequent elective iurgical revascularization once the patient is stable enough
ay be a consideration.
Reported mortality related to acute mesenteric arterial
cclusion remains high.8 Although endovascular therapy in
MI remains controversial, mounting literature suggests
n important role that could be played by these emerging
echnologies.5,9 In fact, recent pooled analysis of revascu-
arization procedures performed for AMI in Sweden shows
current predominance of endovascular techniques, which
s a complete trend reversal since 2004.10 Our study con-
rms the feasibility of revascularization in patients present-
ng with acute mesenteric ischemic syndrome. However, it
hould be stressed that patients in our study who presented
ith the acute mesenteric syndromes either presented with
linically milder variants (n  7) or had open abdominal
xploration as a component of the management either in
onjunction with endovascular recanalization. Needless to
ay, successful endovascular recanalization of vascular oc-
lusions in this setting should not replace the need for
areful assessment of bowel viability. While in patients with
ild physical and laboratory findings, a conservative ap-
roach with careful follow-up may be applicable, there
hould be no hesitation about implementing a routine
econd-look strategy (open or laparoscopic) to avert the
otential disastrous consequences of missed gangrenous
owel transformation.
An interesting observation in our series is the relative
aucity of thrombus burden despite the high clinical prev-
lence of acute mesenteric ischemic syndrome (38%). Only
wo lesions (20%) were suspected of having a thrombotic
omponent based on CT angiography. Catheter angiogra-
hy demonstrated a small thrombus burden in both, which
as treated with pulse-spray thrombolysis in one and pri-
ary stent graft placement in the other. No angiographi-
ally significant embolic events were detected, but the
otential for microembolization, which may have serious
etrimental consequences on bowel viability in these com-
romised patients, cannot be excluded. Associated occult
hrombus in these chronic occlusions may also have an
dverse effect on long-term patency. An argument may
hus be made for routine administration of a thrombolytic
gent prior to stenting. Angiographically visible thrombosis
ay be rapidly managed with a brief course of pulse-spray
hrombolysis, aspiration thrombectomy, or mechanical
hrombectomy using a flexible over-the-wire device.11,12
he use of primary stent graft deployment may also provide
viable option in patients where acute revascularization is
esired. Stenting of the SMA has been proposed by some as
n alternative in treating thrombotic occlusion. Balloon-
xpandable stents are used to treat stiff ostial lesions, and
elf-expanding stents are then used as distal extensions,
chieving a smoother transition to the native SMA.5
Another important observation is the reduced patency
nd high clinical recurrence rates in smaller vessels necessi-
ating a stent 5 mm or smaller in nominal diameter. This
rend has been previously observed in renal artery stent-
ng.13 An argument can therefore be made for the use of
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also proven of potential value in small renal arteries.13
Our study also suggested a high rate of access-related
complications, predominantly related to the frequent use of
brachial access. These included hematomas, pseudoaneu-
rysms, and thrombosis. A point can be made about the
importance of access under ultrasound guidance at the level
of the antecubital fossa, and not waiting for normalization
of the activated clotting time before sheath withdrawal. In
patients with small disease brachial arteries, access via a cut
down may be prudent.
Our study also brings up the deficiency of the current
native mesenteric vessels criteria for stenosis. The currently
used duplex criterion for significant SMA stenosis (70%) is
PSV 275 cm/s.14 We have found even a more lenient
duplex criterion (PSV 300 cm/s) to correlate poorly with
clinical symptom recurrence. A threshold of PSV400 cm/s
correlated better with clinical recurrences. These drawbacks of
duplex evaluation of the stented SMA have been previously
described.15Other problemswith duplex include its operator-
dependent nature, frequent poor visualization in nonfasting
patients due to overlying bowel gas, and its known depen-
dence on prandial status. Our approach has been to obtain a
baseline study immediately following a technically successful
stenting procedure.We have a higher arbitrary threshold (400
cm/s) that we use as screening tool, and place a greater
emphasis on short-term serial follow-up studies. Progressive
elevated velocities 400 cm/s or high clinical suspicion of
recurrence should trigger further evaluations using computed
tomography angiography or catheter angiography.
In conclusion, our experience in this challenging group of
patients supports the feasibility and short-term clinical efficacy
of endovascular recanalization of total occlusions of the supe-
riormesenteric and celiac arteries, provided careful planning is
used. CT and good-quality fixed lateral fluoroscopy were
crucial for the localization of the stump and to plan the level of
probing on angiography during the recanalization procedure,
even when a stump was not visualized on angiography.
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